Robin Besuyen, MD

 

Europital has done a great job in providing medical monitors to our phase 2 program in psoriatic arthritis and axial spondyloarthritis. The team of physicians was very well trained to perform safety oversight and medical data review. They have significantly contributed to the quality of the data in these studies. Over the course of time, […]

 

 

 

Dear Europital, I would like to take this opportunity to thank you and your team for the hard work and support on the Peruse study. Particularly, Mohamed for his valuable contribution on the Peruse study! Mohamed, it has been a very high pleasure to work with you and on behalf of the Roche team, I would like […]

 

 

Sally Adams, PhD

 

Since 2015, Europital’s CEO and Chief Medical Officer, Dr Mohamed El Malt, has provided medical advice and support for Scancell’s ImmunoBody® clinical trials and has recently been involved in the design of a new trial protocol relating to its Moditope® platform. It has been a pleasure working with him. Mohamed and his team of physicians […]

 

 

 

A medium-size biotech is developing a novel treatment against Respiratory Syncytial Virus. They started their Phase I First-in-Infant study and, within the same time period, planned for the Phase II study in the same program.

 

 

View the Latest News

 

 

Message from the Europital CEO

To our Clients, Staff and Partners

Since the reporting of first cases of COVID-19 infection, Europital management has kept a close eye on the evolvement of this novel virus and continuously assessed the risk associated with the spread of infection in other parts of the world...  [read more]